MDxHealth SA
MDXH
$0.55
-$0.02-2.78%
NASDAQ
| 12/31/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 29.55M | 24.29M | 24.74M | 23.32M | 22.16M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.55M | 24.29M | 24.74M | 23.32M | 22.16M |
| Cost of Revenue | 10.86M | 8.79M | 9.22M | 9.04M | 8.87M |
| Gross Profit | 18.69M | 15.50M | 15.52M | 14.28M | 13.29M |
| SG&A Expenses | 19.63M | 15.66M | 15.57M | 16.35M | 16.48M |
| Depreciation & Amortization | 1.25M | 1.32M | 1.33M | 1.33M | 1.12M |
| Other Operating Expenses | -206.00K | 608.00K | 441.00K | -11.00K | -40.00K |
| Total Operating Expenses | 34.81M | 28.88M | 29.35M | 29.41M | 29.33M |
| Operating Income | -5.26M | -4.59M | -4.61M | -6.09M | -7.18M |
| Income Before Tax | -10.50M | -9.07M | -6.79M | -10.85M | -11.53M |
| Income Tax Expenses | -1.57M | 137.00K | 48.00K | 344.00K | -- |
| Earnings from Continuing Operations | -8.93M | -9.21M | -6.84M | -11.19M | -11.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.93M | -9.21M | -6.84M | -11.19M | -11.53M |
| EBIT | -5.26M | -4.59M | -4.61M | -6.09M | -7.18M |
| EBITDA | -2.82M | -2.34M | -2.42M | -3.94M | -5.38M |
| EPS Basic | -0.17 | -0.19 | -0.14 | -0.40 | -0.42 |
| Normalized Basic EPS | -0.01 | -- | 0.00 | -- | -0.16 |
| EPS Diluted | -0.17 | -0.19 | -0.14 | -0.40 | -0.42 |
| Normalized Diluted EPS | -0.01 | -- | 0.00 | -- | -0.16 |
| Average Basic Shares Outstanding | 52.52M | 48.47M | 48.86M | 27.97M | 27.45M |
| Average Diluted Shares Outstanding | 52.52M | 48.47M | 48.86M | 27.97M | 27.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |